SCHEMBL20692234

SCHEMBL20692234

COP(O)OCC1CCC(n2cnc3c(OCCc4ccc([N+](=O)[O-])cc4)nc4nccn4c32)O1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 1/20 0.32
▸ SLC29A1 Q99808 11/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24060657 0.89 SLC29A1 (0.32) CNR2SLC29A1
SCHEMBL20691951 0.88 SLC29A1 (0.37) SLC29A1
SCHEMBL24680745 0.87 SLC29A1 (0.32) SLC29A1
SCHEMBL20692222 0.80 ALDH1A1 (0.32) —
SCHEMBL25688810 0.78 SLC29A1 (0.45) SLC29A1
SCHEMBL20691367 0.77 SLC29A1 (0.51) SLC29A1
SCHEMBL22349184 0.75 SLC29A1 (0.47) SLC29A1
SCHEMBL25688811 0.73 SLC29A1 (0.36) SLC29A1
SCHEMBL20692032 0.72 ALDH1A1 (0.38) —
SCHEMBL20692059 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3658565-B1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS BRISTOL MYERS SQUIBB CO (US) 2022-11-09 — — EP disclosed
WO-2019023459-A1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2019-01-31 — — WO disclosed
Send feedback